MedPath

Randomised placebo controlled study on the safety and efficacy of a herbal tonic for cessation of smoking - five week pilot study

Phase 2
Completed
Conditions
Smoking
Public Health - Health promotion/education
Registration Number
ACTRN12605000296639
Lead Sponsor
CigArrest Pty ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1) 3 or more years as a smoker 2) Smoke greater than or equal to 20 cigarettes per day 3) Fagerstrom greater than or equal to 5 4) Exhaled carbon monoxide concentration greater than or equal to 10ppm 5) In good general health.

Exclusion Criteria

1) Pregnant or lactating females or women likely to become prgnant during the study2) History of serious or unstable cardiac, renal, hypertensive, pulmonary, endocrine, neurologic or neuropsychiatric disorders 3) History of alcohol or substance abuse4) Regular use of any non-cigarette tobacco products5) Current use of other smoking cessation treatments6) Use of any complementary medicine smoking cessation products in the previous 6 months7) Clinically abnormal liver function at baseline8) Unwilling to comply with study protocol9) Subjects who have participated in another clinical trial in the last 30 days10) Any other condition which in the opinion of the investigators could compromise the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self reported abstinence from smoking for the final 4 weeks before the 5 week visit of the clinical trial. Subjects' reports of abstinence are verified by exhaled carbon monoxide levels of no greater then 10ppm.[]
Secondary Outcome Measures
NameTimeMethod
1) Change in Fagerstrom score[At week 5];2) Difference in daily withdrawal symptoms between active and placebo[Over 5 weeks];3) Difference in daily occasions of cravings between active and placebo[Over 5 weeks.]
© Copyright 2025. All Rights Reserved by MedPath